chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity, Presyncope
Clinical narrative: Vasovagal reaction; allergic reaction to vaccine; became lightheaded, dizzy; mildly short of breath; developed a headache/onset 6 out of 10 left-sided frontal headache; chest tightness; room is spinning around her however does not feel that she is presyncopal; This is a spontaneous report from a contactable pharmacist. A 49-year-old female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EJ1685; expiration date: unknown), intramuscular left arm on 18Dec2020 20:00 at a single dose for covid-19 immunization. Medical history included wheezing, hypertension, hyperlipidaemia and non-insulin-dependent diabetes. She was not diagnosed with Covid prior to vaccination. The patient has no known allergies. It was unknown if the patient was pregnant at the time of vaccination. Concomitant medication included salbutamol sulfate (ALBUTEROL) for wheezing, fluticasone propionate (FLOVENT HFA), hydrochlorothiazide, losartan potassium (LOSARTAN HYDROCHLOROTHIAZIDE ACTAVIS), pravastatin, colecalciferol (VIT D3), colecalciferol (VITAMIN D3 1000), latanoprost and metformin. The patient did not receive other vaccine in the last four weeks. On 18Dec2020, the patient reported that she received her first Covid 19 vaccination shot in a hospital and shortly thereafter became lightheaded, dizzy, mildly short of breath, and developed a headache. She further reported that her symptoms occurred approximately 10 to 15 minutes (reported onset time of 08:00 PM) after receiving the shot and started after she walked a short distance and then sat down when she became mildly short of breath, had one episode of chest tightness that since resolved. She also had acute onset 6 out of 10 left-sided frontal headache that has stayed constant since onset. She feels that the room is spinning around her however does not feel that she is presyncopal. The impression was vasovagal reaction with mild allergic reaction to vaccine. The adverse events resulted in an emergency room/department or urgent care visit and treatment was received for the adverse events which included ketorolac 15mg x 1 dose, meclizine 25mg x 1 dose, NaCl 1,000 mL bolus. The patient was not COVID tested post vaccination. The outcome of the events was recovered on an unspecified date.; Sender's Comments: Based on the compatible time association, the possible contribution of suspect vaccine BNT162B2 to the events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Pharyngeal swelling
Clinical narrative: Resident was given the vaccine at 1:51 pm. on 1/20/21. After the fifteen minute waiting period, resident left the observation area. At 2:08 pm, resident reported shortness of breath. SSM and RN tracked down staff from outside. Staff administered epi-pen to resident and called 911. When EMS arrived, they took vitals and reported vitals were stable and pulse ox level within normal means.  No rash or swelling. Resident refused to go to hospital. EMS stated resident should be fine as no allergic reaction was observed. SSM and LRA spoke with resident and got permission to check on him 1x per hour for next four hours (as suggested by RN on site).  After paramedics left resident was observed walking dog with no sign of distress. RN called to report incident to primary care physician. At 230pm on 1/20/21 RN received called from staff at building where resident lives to report that after reviewing the video survelliance tape that at the same time of the incident with resident with SOB; an unauthorized guest was seen running out of patient's apartment. This placed the validity of distress into question. Clinic RN called to follow up with patient per RN he stated, "I felt short of breath but I'm fine now." Staff RN then called Clinic RN to report that the resident had an unauthorized guest run out at same time of incident. Follow up checks on client continued to find resident without symptoms.
Age: 31.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea
Clinical narrative: Resident was given the vaccine at 1:51 pm. on 1/20/21. After the fifteen minute waiting period, resident left the observation area. At 2:08 pm, resident reported shortness of breath. SSM and RN tracked down staff from outside. Staff administered epi-pen to resident and called 911. When EMS arrived, they took vitals and reported vitals were stable and pulse ox level within normal means.  No rash or swelling. Resident refused to go to hospital. EMS stated resident should be fine as no allergic reaction was observed. SSM and LRA spoke with resident and got permission to check on him 1x per hour for next four hours (as suggested by RN on site).  After paramedics left resident was observed walking dog with no sign of distress. RN called to report incident to primary care physician. At 230pm on 1/20/21 RN received called from staff at building where resident lives to report that after reviewing the video survelliance tape that at the same time of the incident with resident with SOB; an unauthorized guest was seen running out of patient's apartment. This placed the validity of distress into question. Clinic RN called to follow up with patient per RN he stated, "I felt short of breath but I'm fine now." Staff RN then called Clinic RN to report that the resident had an unauthorized guest run out at same time of incident. Follow up checks on client continued to find resident without symptoms.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Generalised tonic-clonic seizure
Clinical narrative: Approximately 22 hours after vaccination had a seizure. Felt fine up until the seizure occurred. Never had a seizure in past. No other illness or symptoms. No fever or change in blood sugar.; This is a spontaneous report from a contactable Physician. A 75-year-female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Intramuscular on 18Jan2021 19:30 at single dose on left arm for COVID-19 immunization. Medical history included Stroke, diabetes, hypertension, anaphylaxis to bee stings. The patient had no covid prior vaccination. The patient had no covid tested post vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included sitagliptin phosphate (JANUVIA), hydrochlorothiazide, telmisartan, rivaroxaban (XARELTO), gabapentin and baclofen. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously had allergy to Morphine and experienced Hives. Approximately 22 hours after vaccination the patient had a seizure on 19Jan2021 17:15. She felt fine up until the seizure occurred. She never had a seizure in past. No other illness or symptoms. No fever or change in blood sugar. No treatment was received for the event. The patient had not been tested for COVID-19 since the vaccination. The outcome of the event was resolved.  Information on the lot/Batch number has been requested.; Sender's Comments: Based on the time association and previously allergic reactions to bee stings and other drugs, the possible contribution of suspect BNT162B2 to the event seizure cannot be excluded in this elderly patient with multiple medical histories including stroke, diabetes and hypertension. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose normal, Seizure
Clinical narrative: Approximately 22 hours after vaccination had a seizure. Felt fine up until the seizure occurred. Never had a seizure in past. No other illness or symptoms. No fever or change in blood sugar.; This is a spontaneous report from a contactable Physician. A 75-year-female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Intramuscular on 18Jan2021 19:30 at single dose on left arm for COVID-19 immunization. Medical history included Stroke, diabetes, hypertension, anaphylaxis to bee stings. The patient had no covid prior vaccination. The patient had no covid tested post vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included sitagliptin phosphate (JANUVIA), hydrochlorothiazide, telmisartan, rivaroxaban (XARELTO), gabapentin and baclofen. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously had allergy to Morphine and experienced Hives. Approximately 22 hours after vaccination the patient had a seizure on 19Jan2021 17:15. She felt fine up until the seizure occurred. She never had a seizure in past. No other illness or symptoms. No fever or change in blood sugar. No treatment was received for the event. The patient had not been tested for COVID-19 since the vaccination. The outcome of the event was resolved.  Information on the lot/Batch number has been requested.; Sender's Comments: Based on the time association and previously allergic reactions to bee stings and other drugs, the possible contribution of suspect BNT162B2 to the event seizure cannot be excluded in this elderly patient with multiple medical histories including stroke, diabetes and hypertension. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bell's palsy
Clinical narrative: Bell's palsy / pain in the left side of her face / pain irradiated to ear and jaw / tingling sensation in left side of the forehead / facial weakness; This is a spontaneous report from a contactable Physician reported for self. This 35-Year-old-female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via Intramuscular on 15Jan2021 08:20 on Arm left at single dose for covid-19 immunisation. No other vaccine in four weeks. No Covid prior vaccination. No known allergies. None concomitant medication included. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 24Dec2020 08:20 AM at the age of 35 year old via IM Injection Upper Left Arm for covid-19 immunisation, no reactions with first dose and flu vaccine, Expiry Date: Oct2020 for immunization and no reactions. The patient experienced Bell's palsy on 19Jan2021 and received prednisone 60 mg for 7 days. The same day of the vaccination (15Jan2021), she started to experience pain in the left side of her face, aggravated by 18Jan2021, her pain irradiated to ear and jaw. On Saturday 16 post vaccinated, she experienced also tingling sensation in left side of the forehead on 16Jan2021. She experienced facial weakness on 19Jan2021. And in 19Jan Monday evening Bells Palsy was confirmed. Lab data included Physical exams: weakness in the left side of forehead. No Covid tested post vaccination. Outcome of the event Bell's palsy was recovering. Outcome of other events was unknown. There was a reasonable possibility that the event Bell's palsy was related to BNT162B2.  Information on Lot/Batch number has been requested.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the event facial paralysis cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ear pain, Facial pain, Facial paralysis, Facial paresis, Pain
Clinical narrative: Bell's palsy / pain in the left side of her face / pain irradiated to ear and jaw / tingling sensation in left side of the forehead / facial weakness; This is a spontaneous report from a contactable Physician reported for self. This 35-Year-old-female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via Intramuscular on 15Jan2021 08:20 on Arm left at single dose for covid-19 immunisation. No other vaccine in four weeks. No Covid prior vaccination. No known allergies. None concomitant medication included. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 24Dec2020 08:20 AM at the age of 35 year old via IM Injection Upper Left Arm for covid-19 immunisation, no reactions with first dose and flu vaccine, Expiry Date: Oct2020 for immunization and no reactions. The patient experienced Bell's palsy on 19Jan2021 and received prednisone 60 mg for 7 days. The same day of the vaccination (15Jan2021), she started to experience pain in the left side of her face, aggravated by 18Jan2021, her pain irradiated to ear and jaw. On Saturday 16 post vaccinated, she experienced also tingling sensation in left side of the forehead on 16Jan2021. She experienced facial weakness on 19Jan2021. And in 19Jan Monday evening Bells Palsy was confirmed. Lab data included Physical exams: weakness in the left side of forehead. No Covid tested post vaccination. Outcome of the event Bell's palsy was recovering. Outcome of other events was unknown. There was a reasonable possibility that the event Bell's palsy was related to BNT162B2.  Information on Lot/Batch number has been requested.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the event facial paralysis cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in jaw, Paraesthesia, Physical examination normal
Clinical narrative: Bell's palsy / pain in the left side of her face / pain irradiated to ear and jaw / tingling sensation in left side of the forehead / facial weakness; This is a spontaneous report from a contactable Physician reported for self. This 35-Year-old-female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via Intramuscular on 15Jan2021 08:20 on Arm left at single dose for covid-19 immunisation. No other vaccine in four weeks. No Covid prior vaccination. No known allergies. None concomitant medication included. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 24Dec2020 08:20 AM at the age of 35 year old via IM Injection Upper Left Arm for covid-19 immunisation, no reactions with first dose and flu vaccine, Expiry Date: Oct2020 for immunization and no reactions. The patient experienced Bell's palsy on 19Jan2021 and received prednisone 60 mg for 7 days. The same day of the vaccination (15Jan2021), she started to experience pain in the left side of her face, aggravated by 18Jan2021, her pain irradiated to ear and jaw. On Saturday 16 post vaccinated, she experienced also tingling sensation in left side of the forehead on 16Jan2021. She experienced facial weakness on 19Jan2021. And in 19Jan Monday evening Bells Palsy was confirmed. Lab data included Physical exams: weakness in the left side of forehead. No Covid tested post vaccination. Outcome of the event Bell's palsy was recovering. Outcome of other events was unknown. There was a reasonable possibility that the event Bell's palsy was related to BNT162B2.  Information on Lot/Batch number has been requested.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the event facial paralysis cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Muscle twitching, Paraesthesia oral, Pharyngeal paraesthesia
Clinical narrative: felt numbness in mouth; felt numbness in mouth. It spread to arms and hands; Eexperienced muscle twitching in hands; feel dizzy; A light rash covered my chest and arms; My heart rate and blood pressure were elevated; My heart rate and blood pressure were elevated; This is a spontaneous report from a contactable Other Health Professional reported for herself.  A 43-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Jan2021 19:45 for covid-19 immunization, via Left arm in hospital.  Medical history included arthritis from an unknown date and unknown if ongoing.  She had no allergies to medications, food, or other products. Concomitant medication included probiotics (PROBIOTICS) and Multivitamins.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. 20 minutes following injection, the patient experienced felt numbness in mouth, felt numbness in mouth, it spread to arms and hands. She went to ER  (Emergency room/department or urgent care) and started to feel dizzy and experienced muscle twitching in hands, a light rash covered her chest and arms, heart rate and blood pressure elevated, all on 19Jan2021 20:15 with outcome of recovering.  She had no history of these symptoms and was in good health.  The action taken in response to the event(s) for bnt162b2 was not applicable.  She received Benadryl  as a result of events.; Sender's Comments: The reported events  were causally related to the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), due to plausible temporal relationship and clinical course.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Dizziness, Heart rate increased, Hypertension, Hypoaesthesia
Clinical narrative: felt numbness in mouth; felt numbness in mouth. It spread to arms and hands; Eexperienced muscle twitching in hands; feel dizzy; A light rash covered my chest and arms; My heart rate and blood pressure were elevated; My heart rate and blood pressure were elevated; This is a spontaneous report from a contactable Other Health Professional reported for herself.  A 43-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Jan2021 19:45 for covid-19 immunization, via Left arm in hospital.  Medical history included arthritis from an unknown date and unknown if ongoing.  She had no allergies to medications, food, or other products. Concomitant medication included probiotics (PROBIOTICS) and Multivitamins.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. 20 minutes following injection, the patient experienced felt numbness in mouth, felt numbness in mouth, it spread to arms and hands. She went to ER  (Emergency room/department or urgent care) and started to feel dizzy and experienced muscle twitching in hands, a light rash covered her chest and arms, heart rate and blood pressure elevated, all on 19Jan2021 20:15 with outcome of recovering.  She had no history of these symptoms and was in good health.  The action taken in response to the event(s) for bnt162b2 was not applicable.  She received Benadryl  as a result of events.; Sender's Comments: The reported events  were causally related to the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), due to plausible temporal relationship and clinical course.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia oral, Muscle twitching, Rash
Clinical narrative: felt numbness in mouth; felt numbness in mouth. It spread to arms and hands; Eexperienced muscle twitching in hands; feel dizzy; A light rash covered my chest and arms; My heart rate and blood pressure were elevated; My heart rate and blood pressure were elevated; This is a spontaneous report from a contactable Other Health Professional reported for herself.  A 43-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Jan2021 19:45 for covid-19 immunization, via Left arm in hospital.  Medical history included arthritis from an unknown date and unknown if ongoing.  She had no allergies to medications, food, or other products. Concomitant medication included probiotics (PROBIOTICS) and Multivitamins.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. 20 minutes following injection, the patient experienced felt numbness in mouth, felt numbness in mouth, it spread to arms and hands. She went to ER  (Emergency room/department or urgent care) and started to feel dizzy and experienced muscle twitching in hands, a light rash covered her chest and arms, heart rate and blood pressure elevated, all on 19Jan2021 20:15 with outcome of recovering.  She had no history of these symptoms and was in good health.  The action taken in response to the event(s) for bnt162b2 was not applicable.  She received Benadryl  as a result of events.; Sender's Comments: The reported events  were causally related to the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), due to plausible temporal relationship and clinical course.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Fatigue, Full blood count, Haematoma, Metabolic function test
Clinical narrative: On 1/11 resident received vaccine with no initial concerns. She was seen by PCP on 1/13 . O2 stats 96-97%  in the a.m.  Bruising on top of chest noted around 1:30 pm. Large swollen area noted on right side of neck as well as left shoulder/neck area. C/O Shortness of breath, dyspnea, audible gargling sound during breathing. O2 stats repeated, 88-90%.  Family was notified and resident was sent out to  Hospital  in the afternoon.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Vomiting
Clinical narrative: On 1/11 resident received vaccine with no initial concerns. She was seen by PCP on 1/13 . O2 stats 96-97%  in the a.m.  Bruising on top of chest noted around 1:30 pm. Large swollen area noted on right side of neck as well as left shoulder/neck area. C/O Shortness of breath, dyspnea, audible gargling sound during breathing. O2 stats repeated, 88-90%.  Family was notified and resident was sent out to  Hospital  in the afternoon.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Breath sounds abnormal, Contusion, Dyspnoea, Peripheral swelling, Swelling
Clinical narrative: On 1/11 resident received vaccine with no initial concerns. She was seen by PCP on 1/13 . O2 stats 96-97%  in the a.m.  Bruising on top of chest noted around 1:30 pm. Large swollen area noted on right side of neck as well as left shoulder/neck area. C/O Shortness of breath, dyspnea, audible gargling sound during breathing. O2 stats repeated, 88-90%.  Family was notified and resident was sent out to  Hospital  in the afternoon.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest discomfort, Loss of consciousness
Clinical narrative: Ten minutes after injection felt lightheaded/dizzy with brief periods of feeling alternately "hot and cold". Then felt some chest tightness with some difficulty breathing but no wheezing, She felt the tightness sensation on her chest. EpiPen administered once with transient improvement of symptoms but then recurred  then administered EpiPen again. Thinks she saw some hives on her chest. Taken by ambulance and administered diphenhydramine 50mg Taken to the ER with no rash, upper/lower respiratory symptoms noted. EKG and cardiac workup negative. Patient discharged after 4 hours after improvement of symptoms with no other treatment given. Serum tryptase sent and 6.4mcg/mL.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest discomfort, Chills, Dizziness, Dyspnoea, Feeling cold
Clinical narrative: Ten minutes after injection felt lightheaded/dizzy with brief periods of feeling alternately "hot and cold". Then felt some chest tightness with some difficulty breathing but no wheezing, She felt the tightness sensation on her chest. EpiPen administered once with transient improvement of symptoms but then recurred  then administered EpiPen again. Thinks she saw some hives on her chest. Taken by ambulance and administered diphenhydramine 50mg Taken to the ER with no rash, upper/lower respiratory symptoms noted. EKG and cardiac workup negative. Patient discharged after 4 hours after improvement of symptoms with no other treatment given. Serum tryptase sent and 6.4mcg/mL.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Feeling hot
Clinical narrative: Ten minutes after injection felt lightheaded/dizzy with brief periods of feeling alternately "hot and cold". Then felt some chest tightness with some difficulty breathing but no wheezing, She felt the tightness sensation on her chest. EpiPen administered once with transient improvement of symptoms but then recurred  then administered EpiPen again. Thinks she saw some hives on her chest. Taken by ambulance and administered diphenhydramine 50mg Taken to the ER with no rash, upper/lower respiratory symptoms noted. EKG and cardiac workup negative. Patient discharged after 4 hours after improvement of symptoms with no other treatment given. Serum tryptase sent and 6.4mcg/mL.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Electrocardiogram, Feeling of body temperature change, Tryptase
Clinical narrative: Ten minutes after injection felt lightheaded/dizzy with brief periods of feeling alternately "hot and cold". Then felt some chest tightness with some difficulty breathing but no wheezing, She felt the tightness sensation on her chest. EpiPen administered once with transient improvement of symptoms but then recurred  then administered EpiPen again. Thinks she saw some hives on her chest. Taken by ambulance and administered diphenhydramine 50mg Taken to the ER with no rash, upper/lower respiratory symptoms noted. EKG and cardiac workup negative. Patient discharged after 4 hours after improvement of symptoms with no other treatment given. Serum tryptase sent and 6.4mcg/mL.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Ten minutes after injection felt lightheaded/dizzy with brief periods of feeling alternately "hot and cold". Then felt some chest tightness with some difficulty breathing but no wheezing, She felt the tightness sensation on her chest. EpiPen administered once with transient improvement of symptoms but then recurred  then administered EpiPen again. Thinks she saw some hives on her chest. Taken by ambulance and administered diphenhydramine 50mg Taken to the ER with no rash, upper/lower respiratory symptoms noted. EKG and cardiac workup negative. Patient discharged after 4 hours after improvement of symptoms with no other treatment given. Serum tryptase sent and 6.4mcg/mL.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dyspnoea, Hypertension, Throat irritation
Clinical narrative: Shortly after vaccine, staff member was noted to be acting 'unusual', drank 3 bottles of water within 1-2min. When asked if she was okay she said yes, but then about 10min later said her heart was racing. VS checked at 2:44p (185/115-91 100%RA) started to feel chilled, some rigors; 2:47p (185/126) 2:51p (172/128) increasing rigors, slight SOB; Took 50mg Benadryl;  EMS alerted at 2:56p; Epi-pen admin around 3p due to changing level of conscience- this improved right after EPI. EMS arrived shortly there after.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abnormal behaviour, Chills, Depressed level of consciousness, Dyspnoea, Palpitations
Clinical narrative: Shortly after vaccine, staff member was noted to be acting 'unusual', drank 3 bottles of water within 1-2min. When asked if she was okay she said yes, but then about 10min later said her heart was racing. VS checked at 2:44p (185/115-91 100%RA) started to feel chilled, some rigors; 2:47p (185/126) 2:51p (172/128) increasing rigors, slight SOB; Took 50mg Benadryl;  EMS alerted at 2:56p; Epi-pen admin around 3p due to changing level of conscience- this improved right after EPI. EMS arrived shortly there after.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Back pain, Computerised tomogram head, Full blood count, Guillain-Barre syndrome, Immunoglobulin therapy
Clinical narrative: Patient presented to emergency department at Hospital on 01/26/2021 with primary complaint of pain that began in both arms and both legs and rapidly progressed to her entire body. Patient described pain as severe (8 to 10), sharp, burning and tingling in both hands. Patient was afebrile, breath sounds even and unlabored, vital signs were within normal limits.  Patient notes that pain started 1 day prior to presenting to emergency department and she has not experienced anything like this before. This patient reported that she received her second dose of the Pfizer COVID-19 vaccine on 01/20/2021. ECG and CT within normal limits. Patient transferred to another hospital for higher level of care per Dr
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Lumbar puncture, Magnetic resonance imaging neck, Metabolic function test, Pain, Pain in extremity
Clinical narrative: Patient presented to emergency department at Hospital on 01/26/2021 with primary complaint of pain that began in both arms and both legs and rapidly progressed to her entire body. Patient described pain as severe (8 to 10), sharp, burning and tingling in both hands. Patient was afebrile, breath sounds even and unlabored, vital signs were within normal limits.  Patient notes that pain started 1 day prior to presenting to emergency department and she has not experienced anything like this before. This patient reported that she received her second dose of the Pfizer COVID-19 vaccine on 01/20/2021. ECG and CT within normal limits. Patient transferred to another hospital for higher level of care per Dr
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Paraesthesia, Viral titre
Clinical narrative: Patient presented to emergency department at Hospital on 01/26/2021 with primary complaint of pain that began in both arms and both legs and rapidly progressed to her entire body. Patient described pain as severe (8 to 10), sharp, burning and tingling in both hands. Patient was afebrile, breath sounds even and unlabored, vital signs were within normal limits.  Patient notes that pain started 1 day prior to presenting to emergency department and she has not experienced anything like this before. This patient reported that she received her second dose of the Pfizer COVID-19 vaccine on 01/20/2021. ECG and CT within normal limits. Patient transferred to another hospital for higher level of care per Dr
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Computerised tomogram normal, Electrocardiogram normal, Pain, Pain in extremity, Paraesthesia
Clinical narrative: Patient presented to emergency department at Hospital on 01/26/2021 with primary complaint of pain that began in both arms and both legs and rapidly progressed to her entire body. Patient described pain as severe (8 to 10), sharp, burning and tingling in both hands. Patient was afebrile, breath sounds even and unlabored, vital signs were within normal limits.  Patient notes that pain started 1 day prior to presenting to emergency department and she has not experienced anything like this before. This patient reported that she received her second dose of the Pfizer COVID-19 vaccine on 01/20/2021. ECG and CT within normal limits. Patient transferred to another hospital for higher level of care per Dr
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Pain
Clinical narrative: Patient presented to emergency department at Hospital on 01/26/2021 with primary complaint of pain that began in both arms and both legs and rapidly progressed to her entire body. Patient described pain as severe (8 to 10), sharp, burning and tingling in both hands. Patient was afebrile, breath sounds even and unlabored, vital signs were within normal limits.  Patient notes that pain started 1 day prior to presenting to emergency department and she has not experienced anything like this before. This patient reported that she received her second dose of the Pfizer COVID-19 vaccine on 01/20/2021. ECG and CT within normal limits. Patient transferred to another hospital for higher level of care per Dr
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pain in extremity, Paraesthesia, SARS-CoV-2 test negative
Clinical narrative: Patient presented to emergency department at Hospital on 01/26/2021 with primary complaint of pain that began in both arms and both legs and rapidly progressed to her entire body. Patient described pain as severe (8 to 10), sharp, burning and tingling in both hands. Patient was afebrile, breath sounds even and unlabored, vital signs were within normal limits.  Patient notes that pain started 1 day prior to presenting to emergency department and she has not experienced anything like this before. This patient reported that she received her second dose of the Pfizer COVID-19 vaccine on 01/20/2021. ECG and CT within normal limits. Patient transferred to another hospital for higher level of care per Dr
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angioedema, Lip swelling, Pruritus, Swollen tongue, Urticaria
Clinical narrative: The event started with the appearance of a few hives. Within an hour the hives were severe, covering most of my body. My tongue started to swell and the swelling increased rapidly. My right hand became very inflamed and swollen. I treated myself with 50mgs of Benadryl.  By the time I reached my local ED, my throat and lips were swelling and I was having difficulty speaking clearly. An epi-pen was administered with fluids, Pepcid and dexamethasone. My ED stay was approximately 3.5 hours in which time the hives abated somewhat and my tongue returned to normal.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Inflammation, Lip swelling, Peripheral swelling, Pharyngeal swelling
Clinical narrative: The event started with the appearance of a few hives. Within an hour the hives were severe, covering most of my body. My tongue started to swell and the swelling increased rapidly. My right hand became very inflamed and swollen. I treated myself with 50mgs of Benadryl.  By the time I reached my local ED, my throat and lips were swelling and I was having difficulty speaking clearly. An epi-pen was administered with fluids, Pepcid and dexamethasone. My ED stay was approximately 3.5 hours in which time the hives abated somewhat and my tongue returned to normal.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Speech disorder, Swollen tongue, Urticaria
Clinical narrative: The event started with the appearance of a few hives. Within an hour the hives were severe, covering most of my body. My tongue started to swell and the swelling increased rapidly. My right hand became very inflamed and swollen. I treated myself with 50mgs of Benadryl.  By the time I reached my local ED, my throat and lips were swelling and I was having difficulty speaking clearly. An epi-pen was administered with fluids, Pepcid and dexamethasone. My ED stay was approximately 3.5 hours in which time the hives abated somewhat and my tongue returned to normal.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat irritation, Throat tightness
Clinical narrative: 01/29/2021 at 0902 given COVID vaccine. Approximately 0904 began symptoms of Itchy tongue and throat confusion, light headed, headache and throat swelling.  Given the following: 0915 - 25mg Benadryl IM 0921- 0.3ml Epinephrine IM Went to Emergency room for monitoring and was released at 1230 same day.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Dizziness, Headache, Pharyngeal swelling, Throat irritation
Clinical narrative: 01/29/2021 at 0902 given COVID vaccine. Approximately 0904 began symptoms of Itchy tongue and throat confusion, light headed, headache and throat swelling.  Given the following: 0915 - 25mg Benadryl IM 0921- 0.3ml Epinephrine IM Went to Emergency room for monitoring and was released at 1230 same day.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tongue pruritus
Clinical narrative: 01/29/2021 at 0902 given COVID vaccine. Approximately 0904 began symptoms of Itchy tongue and throat confusion, light headed, headache and throat swelling.  Given the following: 0915 - 25mg Benadryl IM 0921- 0.3ml Epinephrine IM Went to Emergency room for monitoring and was released at 1230 same day.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Hypertension, Tachycardia
Clinical narrative: Lightheadedness, tachycardia
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Tachycardia
Clinical narrative: Lightheadedness, tachycardia
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Pruritus
Clinical narrative: Pfizer-BioNTech was administered at 4:19 pm, she was advised she would need to wait 30 for any adverse reaction.  At 4:25pm  patient started to fee palpations, braking out with redness on her chest and her left arm where the vaccine was administrated.  Epinephrine 0.3 mg auto injector was given in her right thigh by the doctor. We then called 911 to transport her to the emergency room.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Palpitations
Clinical narrative: Pfizer-BioNTech was administered at 4:19 pm, she was advised she would need to wait 30 for any adverse reaction.  At 4:25pm  patient started to fee palpations, braking out with redness on her chest and her left arm where the vaccine was administrated.  Epinephrine 0.3 mg auto injector was given in her right thigh by the doctor. We then called 911 to transport her to the emergency room.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rhinorrhoea, Sinus operation, Throat irritation
Clinical narrative: This is what I felt during the vaccination: within the minute i felt pain in my chest and back (left side) as we drove from the vaccine station to the medic tent for the 15 min observation. then My throat and tongue started itching and drainage from my nose that makes it hard to swallow bc so much was coming down at once  my neck got a red rash, and then my head started feeling heavy.  my heartrate was up when they first measured it but probably because i started panicking. Within the first minute I could also taste the vaccine (kind of like how when saline is flushed in an IV it can be tasted) and that lasted a few hours. Ten mins after taking the vaccine I took a Zyrtec and ten minutes later the rash got better and I started feeling better. The nose and throat got better abt 1.5 hrs after reaction. I felt extremely tired and beat up until the next day In the following days I was better. I still had drainage from my nose and my throat was bothering (itchy) , but not like the first day.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Chest pain, Dysgeusia, Fatigue, Head discomfort
Clinical narrative: This is what I felt during the vaccination: within the minute i felt pain in my chest and back (left side) as we drove from the vaccine station to the medic tent for the 15 min observation. then My throat and tongue started itching and drainage from my nose that makes it hard to swallow bc so much was coming down at once  my neck got a red rash, and then my head started feeling heavy.  my heartrate was up when they first measured it but probably because i started panicking. Within the first minute I could also taste the vaccine (kind of like how when saline is flushed in an IV it can be tasted) and that lasted a few hours. Ten mins after taking the vaccine I took a Zyrtec and ten minutes later the rash got better and I started feeling better. The nose and throat got better abt 1.5 hrs after reaction. I felt extremely tired and beat up until the next day In the following days I was better. I still had drainage from my nose and my throat was bothering (itchy) , but not like the first day.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Rash, Rash erythematous, Rhinorrhoea, Throat irritation
Clinical narrative: This is what I felt during the vaccination: within the minute i felt pain in my chest and back (left side) as we drove from the vaccine station to the medic tent for the 15 min observation. then My throat and tongue started itching and drainage from my nose that makes it hard to swallow bc so much was coming down at once  my neck got a red rash, and then my head started feeling heavy.  my heartrate was up when they first measured it but probably because i started panicking. Within the first minute I could also taste the vaccine (kind of like how when saline is flushed in an IV it can be tasted) and that lasted a few hours. Ten mins after taking the vaccine I took a Zyrtec and ten minutes later the rash got better and I started feeling better. The nose and throat got better abt 1.5 hrs after reaction. I felt extremely tired and beat up until the next day In the following days I was better. I still had drainage from my nose and my throat was bothering (itchy) , but not like the first day.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tongue pruritus
Clinical narrative: This is what I felt during the vaccination: within the minute i felt pain in my chest and back (left side) as we drove from the vaccine station to the medic tent for the 15 min observation. then My throat and tongue started itching and drainage from my nose that makes it hard to swallow bc so much was coming down at once  my neck got a red rash, and then my head started feeling heavy.  my heartrate was up when they first measured it but probably because i started panicking. Within the first minute I could also taste the vaccine (kind of like how when saline is flushed in an IV it can be tasted) and that lasted a few hours. Ten mins after taking the vaccine I took a Zyrtec and ten minutes later the rash got better and I started feeling better. The nose and throat got better abt 1.5 hrs after reaction. I felt extremely tired and beat up until the next day In the following days I was better. I still had drainage from my nose and my throat was bothering (itchy) , but not like the first day.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, External ear pain, Headache, Magnetic resonance imaging normal, Pain of skin
Clinical narrative: Possible Bells Palsy
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tongue disorder
Clinical narrative: Possible Bells Palsy
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Possible Bells Palsy
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA After 10 minutes of receiving the vaccine, my throat started to swell making it difficult to swallow.  A nurse administered 25mg of Benadryl then five minutes later administered an adult dose EPI Pen shot. I was then taken to the emergency room for further observations. Symptom cleared after about an hour after the EPI Pen shot was given.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Pharyngeal swelling
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA After 10 minutes of receiving the vaccine, my throat started to swell making it difficult to swallow.  A nurse administered 25mg of Benadryl then five minutes later administered an adult dose EPI Pen shot. I was then taken to the emergency room for further observations. Symptom cleared after about an hour after the EPI Pen shot was given.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute coronary syndrome, Chest pain, Chills, Echocardiogram, Ejection fraction
Clinical narrative: Adverse Event: Myopericarditis, Non ST elevation myocardial infarction, acute systolic heart failure Treatment: Aspirin 81 mg, Colchicine 0.6 mg, Ibuprofen 600 mg, Metoprolol 12.5 mg Symptoms/Signs: Sharp chest pain worse with inspiration starting  2 days after vaccination Time Course: 2 days following administration of second Moderna vaccine Outcome:  Patient underwent left heart catheterization to rule out coronary artery disease given positive troponin as well as ST segment changes on EKG. Was discharged home the following day after admission
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram ST segment elevation, Pain, Pericarditis, Pyrexia, Troponin increased
Clinical narrative: Adverse Event: Myopericarditis, Non ST elevation myocardial infarction, acute systolic heart failure Treatment: Aspirin 81 mg, Colchicine 0.6 mg, Ibuprofen 600 mg, Metoprolol 12.5 mg Symptoms/Signs: Sharp chest pain worse with inspiration starting  2 days after vaccination Time Course: 2 days following administration of second Moderna vaccine Outcome:  Patient underwent left heart catheterization to rule out coronary artery disease given positive troponin as well as ST segment changes on EKG. Was discharged home the following day after admission